Buchwald, B.; Zhang, G.; Vogt-Eisele, A.; Zhang, W.; Ahangari, R.; Griffin, J. W.; Hatt, H.; Toyka, K. V.; Sheikh, K. A.: Different monoclonal anti-ganglioside antibodies show distinct effects on presynaptic transmitter release and calcium influx. Journal of Neurology 253 (Suppl. 2), p. 11 - 11 (2006)

Steiner, M.; Marsicano, G.; Holsboer, F.; Lutz, B.; Wotjak, C. T.: Cannabinoid receptor 1 (CB1) signaling acts as a major regulatory mechanism of hypothalamus-pituitary-adrenal (HPA) axis mediated corticosterone secretion. Frontiers in Neuroendocrinology 27 (1), p. 39 - 39 (2006)

Armitage, R.; Holsboer-Trachsler, E.; Antonijevic, I. A.; Schuessler, P.: The role of age and gender in changes of sleep-EEG and nocturnal hormone secretion in depression. Biological Psychiatry 59 (8 Suppl. S), pp. 183S - 184S (2006)

Erhardt, A.; Ising, M.; Unschuld, P. G.; Kern, N.; Lucae, S.; Holsboer, F.; Keck, M. E.: Responsiveness of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Biological Psychiatry 59 (8 Suppl. S), p. 200S - 200S (2006)

Holsboer, F.: GR/MR imbalances in depression and anxiety. Biological Psychiatry 59 (8 Suppl. S), p. 1S - 1S (2006)

Quante, A.; Lauterbach, E.; Ahrens, B.; Felber, W.; Müller-Oerlinghausen, B.; Kilb, B.; Heuser, I.; Anghelescu, I.; Hawellek, B.; Meier, W. et al.; Lewitzka, U.; Pogarell, O.; Hegeri, U.; Bronisch, T.; Hohagen, F.: Lithium therapy in patients with suicidal behaviour- the first prospective, placebo controlled trial in comparison to lithium therapy studies in patients only suffering from affective disorders. Biological Psychiatry 59 (8 Suppl. S), p. 38S - 38S (2006)

Rujescu, D.; Bender, A.; Keck, M.; Hartmann, A. M.; Ohl, F.; Raeder, H.; Giegling, I.; Genius, J.; McCarley, R. W.; Möller, H. J. et al.; Grunze, H.: A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: Molecular, cellular, functional and Behavioral abnormalities. Biological Psychiatry 59 (8), pp. 721 - 729 (2006)

Steiner, M. A.; Wanisch, K.; Borroni, E.; Marsicano, G.; Holsboer, F.; Wotjak, C. T.; Lutz, B.: Genetic knockout and pharmacological blockade of cannabinoid receptor I affect stress coping behaviours in the mouse forced swim test. Biological Psychiatry 59 (8, Suppl. S), p. 163S - 163S (2006)

van Rossum, E. F. C.; Binder, E. B.; Majer, M.; Koper, J. W.; Ising, M.; Modell, S.; Salyakina, D.; Lamberts, S. W. J.; Holsboer, F.: Polymorphisms of the glucocorticoid receptor gene and major depression. Biological Psychiatry 59 (8), pp. 681 - 688 (2006)

Correa-De-Santana, E.; Paez-Pereda, M.; Theodoropoulou, M.; Nihei, O. K.; Gruebler, Y.; Bozza, M.; Arzt, E.; Villa-Verde, D. M. S.; Renner, U.; Stalla, J. et al.; Stalla, G. K.; Savino, W.: Hypothalamus-pituitary-adrenal axis during Trypanosoma cruzi acute infection in mice. Journal of Neuroimmunology 173 (1-2), pp. 12 - 22 (2006)

Hummel, M.; Schaaf, L.; Füchtenbusch, M.; Standl, E.; Ziegler, A.: Hypertonie, Hypokaliämie und rasch progrediente Ödeme bei einem 62-jährigen Diabetiker. Internist 47 (4), pp. 427 - 433 (2006)

Landgraf, R.: The brain vasopressin system is a final common pathway in trait anxiety and depression-like behavior. Neuropeptides 40 (2), pp. 142 - 143 (2006)

Ninkovic, J.; Folchert, A.; Makhankov, Y. V.; Neuhauss, S. C. F.; Sillaber, I.; Straehle, U.; Bally-Cuif, L.: Genetic identification of AChE as a positive modulator of addiction to the psychostimulant D-amphetarnine in zebrafish. Journal of Neurobiology 66 (5), pp. 463 - 475 (2006)

Schmid, D. A.; Wichniak, A.; Uhr, M.; Ising, M.; Brunner, H.; Held, K.; Weikel, J. C.; Sonntag, A.; Steiger, A.: Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine. Neuropsychopharmacology 31 (4), pp. 832 - 844 (2006)

Schneider, H. J.; Klotsche, J.; Stalla, G. K.; Wittchen, H. U.: Obesity and risk of myocardial infarction: the INTERHEART study. Lancet 367 (9516), p. 1052 - 1052 (2006)

Binder, E. B.; Lucae, S.; Salyakina, D.; Lichtner, P.; Meitinger, T.; Bondy, B.; Wochnik, G.; Rein, T.; Holsboer, F.; Müller-Myhsok, B.: SNPs in FKBP5 determine a novel subtype of depression characterized by rapid response to antidepressant treatment. European Neuropsychopharmacology 16 (Suppl. 1), p. S75 - S75 (2006)

Ditzen, C.; Tang, N.; Jacob, A.; Uhr, M.; Miller, C.; Turck, C. W.: Biomarker discovery in cerebrospinal fluid of depressed patients. European Neuropsychopharmacology 16 (Suppl. 1), pp. S19 - S20 (2006)

Erhardt, A.; Unschuld, P. G.; Lucae, S.; Ising, M.; Salyakina, D.; Pütz, B.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.; Keck, M. E.: Possible genetic implications of the endo-cannabinoid system in anxiety disorders versus depressive disorders. European Neuropsychopharmacology 16 (Suppl. 1), p. S88 - S88 (2006)

Haider, N.; Wotjak, C.; Hofmann, F.; Moosmang, S.: L-type voltage-gated calcium channels contribute to fear memory formation in the lateral amygdala. Naunyn-Schmiedebergs Archives of Pharmacology 372 (Suppl. 1), p. 60 - 60 (2006)

Kovacs, L.; Yassouridis, A.; Zimmermann, A.; Brockmann, G.; Wohnl, A.; Blaschke, M.; Eder, M.; Schwenzer-Zimmerer, K.; Rosenberg, R.; Papadopulos, N. A. et al.; Biemer, E.: Optimization of 3-dimensional imaging of the breast region with 3-dimensional laser scanners. Annals of Plastic Surgery 56 (3), pp. 229 - 236 (2006)